drugset / Trial / NCT04742010

Summary

In a randomised placebo-controlled trial assess effects of zoledronic acid for prevention of bone and muscle loss after bariatric surgery.

Timeline

Start
2021-02-20
Primary completion
2023-11-01
Completion
2024-08-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Zoledronic acid Other / unclassified 5 mg Intravenous